413 related articles for article (PubMed ID: 18936879)
1. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
2. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
3. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
4. Eye and Behçet's disease.
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
[TBL] [Abstract][Full Text] [Related]
5. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
[TBL] [Abstract][Full Text] [Related]
6. Behçet's syndrome: ocular features in an Australian population.
Wakefield D; McCluskey P
Aust N Z J Ophthalmol; 1990 May; 18(2):129-35. PubMed ID: 2390239
[TBL] [Abstract][Full Text] [Related]
7. Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
Çakar Özdal P
Turk J Ophthalmol; 2020 Jun; 50(3):169-182. PubMed ID: 32631005
[TBL] [Abstract][Full Text] [Related]
8. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.
Gallizzi R; Pidone C; Cantarini L; Finetti M; Cattalini M; Filocamo G; Insalaco A; Rigante D; Consolini R; Maggio MC; Civino A; Martino S; Olivieri AN; Fabio G; Pastore S; Mauro A; Sutera D; Trimarchi G; Ruperto N; Gattorno M; Cimaz R
Pediatr Rheumatol Online J; 2017 Dec; 15(1):84. PubMed ID: 29268757
[TBL] [Abstract][Full Text] [Related]
9. [Eye and Behçet's disease].
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors of ocular involvement in Behçet's disease].
Belkhadir K; Boutimzine N; Laghmari M; Amazouzi A; Tachfouti S; Cherkaoui O
J Fr Ophtalmol; 2019 Jun; 42(6):612-617. PubMed ID: 31088739
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent panuveitis. First manifestation of Behçet disease in childhood].
Mock B; Richter S; Hein G; Wollina U
Ophthalmologe; 1998 Nov; 95(11):784-7. PubMed ID: 9857641
[TBL] [Abstract][Full Text] [Related]
13. [Ocular Behçet].
Alami A; Kriet M; Reda K; Laktaoui A; Oubaaz A
Pan Afr Med J; 2017; 26():237. PubMed ID: 28690751
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects of Behçet's disease--epidemiological features and visual prognosis].
Ando K; Fujino Y; Hijikata K; Izawa Y; Masuda K
Nippon Ganka Gakkai Zasshi; 1997 Oct; 101(10):814-8. PubMed ID: 9369064
[TBL] [Abstract][Full Text] [Related]
16. Behçet's disease in Lebanon: report of 100 cases.
Ghayad E; Tohme A
J Med Liban; 1995; 43(1):2-7. PubMed ID: 8676358
[TBL] [Abstract][Full Text] [Related]
17. [Ocular prognosis in Behçet's disease].
Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
[TBL] [Abstract][Full Text] [Related]
18. Ocular involvement in Behçet's disease.
Peplinski LS
J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
Kötter I; Eckstein AK; Stübiger N; Zierhut M
Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
[TBL] [Abstract][Full Text] [Related]
20. [Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments].
Chung YM; Yeh TS; Sheu MM; Chen MS; Wen MS; Tsai HY; Liao HR
J Formos Med Assoc; 1990 May; 89(5):413-7. PubMed ID: 1977855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
